Warning being added to cholesterol-lowering drug labels
WASHINGTON (WABC) -- The Food and Drug Administration is making changes to the labeling for some widely used cholesterol-lowering drugs known as statins.
These products, when used with diet and exercise, help to lower a person's "bad" cholesterol.
The changes to the statin labels are:
"We want health care professionals and patients to have the most current information on the risks of statins, but also to assure them that these medications continue to provide an important health benefit of lowering cholesterol," said Mary Parks, M.D., a spokesperson for the FDA.
The products include: Lipitor (atorvastatin), Lescol (fluvastatin), Mevacor (lovastatin), Altoprev (lovastatin extended-release), Livalo (pitavastatin), Pravachol (pravastatin), Crestor (rosuvastatin), and Zocor (simvastatin). Combination products include: Advicor (lovastatin/niacin extended-release), Simcor (simvastatin/niacin extended-release), and Vytorin (simvastatin/ezetimibe).
Health care professionals and patients should report any side effects associated with statin use to FDA MedWatch program.
For more information:
Get Eyewitness News Delivered
cholesterol, fda, statins, health news, dr. jay adlersberg
- AccuWeather: More snow Saturday 33 min ago
- Live: Eyewitness News on 7online streamed live!
- Get WATCH ABC for your mobile device
- iWitness Photos and Videos
- Video: Icy cold temperatures hit Tri-State area 28 min ago
- Charges expected in fraternity death
- Mega Millions hits $400M jackpot 14 min ago
- Search for hit and run driver in fatal crash
- LIRR, NJT ban booze ahead of Santacon
- Nassau County police commissioner ousted
- Budget vote approved in the House
- Some from Newtown join vigil at National Cathedral
- Sandy victims turn year of loss into season of giving
- Golden Globes nominations announced
- Icy cold temperatures hit Tri-State area
28 min ago
- AccuWeather: More snow Saturday
33 min ago